Evidence map›Paper›PMID 40155483›Full record

ArticleScientific reports2025

Novel mechanisms of alkyldimethylbenzalkonium chloride in virucidal activity.

Chisato Igarashi, Shun Kubo, Atsuko Hayase, Takuya Mori, Yoshimune Nonomura, Takaya Sakai

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chisato IgarashiResearch and Development, Household Research, Kao Corporation, Wakayama, Japan. igarashi.chisato@kao.com.
Shun KuboResearch and Development, Biological Material Science Research, Kao Corporation, Tochigi, Japan.
Atsuko HayaseResearch and Development, Biological Material Science Research, Kao Corporation, Tochigi, Japan.
Takuya MoriResearch and Development, Biological Material Science Research, Kao Corporation, Tochigi, Japan.
Yoshimune NonomuraDepartment of Applied Chemistry, Chemical Engineering, and Biochemical Engineering, Graduate School of Science and Engineering, Yamagata University, Yamagata, Japan.
Takaya SakaiDepartment of Applied Chemistry, Chemical Engineering, and Biochemical Engineering, Graduate School of Science and Engineering, Yamagata University, Yamagata, Japan. sakai.takaya@kao.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cationic surfactant, alkyldimethylbenzalkonium chloride (BAC), effectively inactivates enveloped viruses, but the underlying mechanism of action is poorly understood. Therefore, this study attempted to elucidate the inactivation mechanism of BAC using actual viruses and characterize the state of BAC in water under the same conditions. Here, we show that at concentrations below the critical micelle concentration (CMC), partial membrane disruption by BAC monomers contributes to the inactivation mechanism. At concentrations above the CMC, solubilization of the envelope component also contributes to virucidal activity. Concentration-related differences in the inactivation mechanism were further evaluated based on the kinetic equation of the reaction, which showed that physicochemical studies are directly related to biochemistry. As enveloped viruses can be viewed as vesicles based on their structure, the results of this study should enhance investigations of non-virus biological vesicles, such as exosomes and drug delivery systems.

Indexed as

Antiviral AgentsBenzalkonium CompoundsAnimalsChlorocebus aethiopsHumansMicellesSurface-Active AgentsVero CellsAntiviral AgentsBenzalkonium CompoundsMicellesSurface-Active Agents

Identifiers

PMID40155483
PMCPMC11953242

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.